Marico购买越南Skinetiq的75%, Marico buys 75% of Vietnam’s Skinetiq for ₹261.6 crore, gaining Murad distribution and Candid brand rights.

印度一家消费品公司Marico已同意在越南Skinetiq公司(Skinetiq)取得75%的股权, Marico, an Indian consumer goods company, has agreed to acquire a 75% stake in Vietnam’s Skinetiq, a digital-first skincare startup, for approximately ₹261.6 crore in a two-tranche deal. 该收购于2026年2月9日宣布,其中包括在越南销售Murad品牌的专有权利以及Candid皮肤保护品牌的所有权。 The acquisition, announced on February 9, 2026, includes exclusive rights to distribute the Murad brand in Vietnam and ownership of the Candid skincare brand. Skinetiq成立于2020年,报告2025年收入和EBITDA20世纪20年代中期的比值为152。 Skinetiq, founded in 2020, reported ₹152 crore in revenue and a mid-twenties EBITDA margin in 2025. 该协议支持Marico在东南亚扩大溢价美观和直接与消费者接触的战略,预计交易将在90天之内结束,等待监管批准。 The deal supports Marico’s strategy to expand its premium beauty and direct-to-consumer presence in Southeast Asia, with the transaction expected to close within 90 days pending regulatory approval. 马里科还可以选择在2028年前获得剩余股份,但取决于业绩里程碑。 Marico also holds an option to acquire the remaining stake by 2028, contingent on performance milestones.